Kunjan Bhatt, MD
Advanced Heart Failure and Transplant Cardiology · Austin, TXNPI 1770668758
Payments from drug & device makers
Across 1,198 payments — averaging $1369.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1.2M
- Cvrx, Inc.$149K
- Bayer$78K
- Pfizer$66K
- Impulse Dynamics (USA) Inc.$50K
- Bridgebio Pharma, Inc.$42K
- plus $28K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 593 | $1,226,598 |
| Cvrx, Inc. | 88 | $149,340 |
| Bayer | 22 | $78,124 |
| Pfizer | 105 | $66,340 |
| Impulse Dynamics (USA) Inc. | 41 | $50,103 |
| Bridgebio Pharma, Inc. | 29 | $42,050 |
| Novartis | 74 | $13,531 |
| AstraZeneca | 27 | $6,497 |
| Abiomed | 49 | $2,641 |
| Alnylam Pharmaceuticals Inc. | 23 | $738 |
| Actelion Pharmaceuticals US, Inc. | 39 | $572 |
| Medtronic(2 entities) | 6 | $521 |
| Merck | 22 | $467 |
| Novo Nordisk | 7 | $432 |
| Boston Scientific | 9 | $395 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $313 |
| Scpharmaceuticals Inc. | 5 | $182 |
| E.r. Squibb & Sons, L.L.C. | 6 | $159 |
| Amgen | 5 | $156 |
| Vifor Pharma, Inc. | 2 | $145 |
| Akcea Therapeutics, Inc. | 2 | $141 |
| Boehringer Ingelheim | 7 | $129 |
| Shockwave Medical, Inc | 1 | $119 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $94 |
| Daiichi Sankyo Inc. | 2 | $56 |
| Johnson & Johnson | 5 | $53 |
| Lantheus Medical Imaging, Inc. | 1 | $35 |
| Lexicon Pharmaceuticals, Inc. | 2 | $35 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Heartflow, Inc. | 1 | $30 |
| Atricure, Inc. | 1 | $21 |
| GE HealthCare | 1 | $21 |
| Sandoz | 1 | $21 |
| United Therapeutics Corporation | 1 | $18 |
| Chiesi USA, Inc. | 1 | $15 |
| Sensible Medical Innovations Inc | 1 | $14 |
How this compares
$1,640,137 in reported general payments places this provider in the 95th percentile of 75 advanced heart failure and transplant cardiology providers in Texas.
See all advanced heart failure and transplant cardiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Austin
- Jerome ThomasAustin$186K
- Clay CauthenAustin$152K
- Raymond BietryAustin$110K
- Andrew ChengAustin$6K
- Robert GottliebDallas$14.1M
- Martin BerkDallas$1.9M
- Ajith NairHouston$1.3M
- Shelley HallDallas$1.3M
- Aasim AfzalPlano$1.2M
- Albert HicksTemple$656K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.